NKF 2012 Anemia Coverage

NKF 2012 Anemia

Peginesatide Requirements Do Not Differ By Race

NATIONAL HARBOR, Md.—Black hemodialysis (HD) patients with anemia require relatively more epoetin than their non-black counterparts to achieve similar hemoglobin (Hb) levels, but blacks and non-blacks required similar peginesatide doses, according to findings presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

Hemoglobin Trends Change in Wake of Bundling

NATIONAL HARBOR, Md.—Researchers have found that hemoglobin levels in dialysis patients have changed since implementation of the bundled payment system for dialysis services in January 2011, according to a report presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

IV Iron Drugs Not Equal in Hemoglobin Response

NATIONAL HARBOR, Md.—In a recently completed clinical trial, treatment with ferumoxytol resulted in a greater hemoglobin (Hb) response than iron sucrose in hemodialysis (HD) patients with anemia and non-dialysis patients with severe anemia, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.

Next post in NKF 2012 Anemia